scholarly article | Q13442814 |
P356 | DOI | 10.1002/PATH.4037 |
P698 | PubMed publication ID | 22488672 |
P50 | author | Thomas A Hughes | Q37383359 |
P2093 | author name string | Eldo T Verghese | |
Ruth Drury | |||
P2860 | cites work | Pathology of soft-tissue tumors: daily diagnosis, molecular cytogenetics and experimental approach | Q37559856 |
MicroRNA-21: a novel therapeutic target in human cancer | Q37817633 | ||
MicroRNA regulation by RNA-binding proteins and its implications for cancer | Q37913018 | ||
A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs | Q38334606 | ||
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma | Q38338166 | ||
S-MED: sarcoma microRNA expression database | Q38431264 | ||
MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers | Q39426037 | ||
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 | ||
MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration | Q39526077 | ||
MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML | Q39531134 | ||
miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. | Q39604058 | ||
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas | Q39608984 | ||
Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma | Q39669508 | ||
EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells | Q39716224 | ||
MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer | Q39736530 | ||
Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples | Q39820788 | ||
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells | Q42009448 | ||
Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma | Q44364850 | ||
MicroRNA expression signature of human sarcomas | Q47836377 | ||
Identification of Differentially Expressed MicroRNAs in Osteosarcoma | Q21296759 | ||
miRBase: integrating microRNA annotation and deep-sequencing data | Q24615914 | ||
Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells | Q24632284 | ||
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development | Q24648202 | ||
Non-coding RNAs in human disease | Q29618039 | ||
microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells | Q33629095 | ||
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours | Q33758070 | ||
RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer | Q33762535 | ||
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells | Q33895297 | ||
MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas | Q33906031 | ||
Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma | Q33938849 | ||
Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development | Q33997274 | ||
A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy | Q34033361 | ||
miR-126 functions as a tumour suppressor in human gastric cancer | Q34125258 | ||
Down-regulation of miR-126 expression in colorectal cancer and its clinical significance | Q34129387 | ||
miRNA expression profiling of lung adenocarcinomas: correlation with mutational status | Q34136203 | ||
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma | Q34228576 | ||
Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells | Q34912570 | ||
MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression | Q35086698 | ||
Advances in sarcoma genomics and new therapeutic targets | Q35993346 | ||
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma | Q37311506 | ||
Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? | Q37325228 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | 385-391 | |
P577 | publication date | 2012-05-23 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | The roles of microRNAs in sarcomas | |
P478 | volume | 227 |
Q39996382 | A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas |
Q38964936 | Epigenetic and genetic changes in soft tissue sarcomas: a review |
Q37235523 | Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. |
Q40786472 | Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors |
Q99406327 | MicroRNA-3148 acts as molecular switch promoting malignant transformation and adipocytic differentiation of immortalized human bone marrow stromal cells via direct targeting of the SMAD2/TGFβ pathway |
Q27006159 | MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers |
Q28085250 | MicroRNAs in the pathobiology of sarcomas |
Q61626102 | microRNAs in the Malignant Transformation Process |
Search more.